2020
DOI: 10.1016/j.csbj.2020.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Methods for sequence and structural analysis of B and T cell receptor repertoires

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 136 publications
0
18
0
Order By: Relevance
“…In addition to immune-cell phenotyping using multiparameter cytometry (flow or mass) and immunoproteomics, gene expression is widely used to identify signatures and predictors of vaccine-induced specific antibody and T-cell responses. Furthermore, transcriptomic and genomic data (using next-generation sequencing) allow to capture the diversity of the immune repertoire induced by vaccines [80], with a comprehensive quantification of full-length T cell receptor (TCR) and B cell receptor (BCR) variable region sequences [81]. Additional layers of information, including epigenomic (using ChIP-Seq or ATAC-Seq), metabolomic (using nuclear magnetic resonance spectroscopy and mass spectrometry), and that from the microbiome (using 16S rRNA or shotgun metagenomic sequencing) can be used to further characterize vaccine responses, as appropriate technologies are becoming available [38,82].…”
Section: Omics Technologiesmentioning
confidence: 99%
“…In addition to immune-cell phenotyping using multiparameter cytometry (flow or mass) and immunoproteomics, gene expression is widely used to identify signatures and predictors of vaccine-induced specific antibody and T-cell responses. Furthermore, transcriptomic and genomic data (using next-generation sequencing) allow to capture the diversity of the immune repertoire induced by vaccines [80], with a comprehensive quantification of full-length T cell receptor (TCR) and B cell receptor (BCR) variable region sequences [81]. Additional layers of information, including epigenomic (using ChIP-Seq or ATAC-Seq), metabolomic (using nuclear magnetic resonance spectroscopy and mass spectrometry), and that from the microbiome (using 16S rRNA or shotgun metagenomic sequencing) can be used to further characterize vaccine responses, as appropriate technologies are becoming available [38,82].…”
Section: Omics Technologiesmentioning
confidence: 99%
“…As more structures for more diverse epitopes and TCRs become available, we expect that both homology modelling accuracy and performance of the classifier will improve. Structure-prediction is now a fast-moving field and we might soon be able to apply newer and improved methods to the TCR-pMHC prediction problem, able to account for the highly diverse CDR loops (Teraguchi et al, 2020 ). Compared to other tools, TCRpMHCmodels is attractive in its ability to produce a quick prediction of the entire TCR-pMHC complex, without relying on docking methods, which still need to be optimised for this task (Peacock and Chain, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Finally, we wish to highlight that this in vivo approach could help to identify new peptide-specific TCR sequences and confirm already established datasets ( Teraguchi et al, 2020 ). Even though TCR datasets are growing, the number of TCRs with known Ag specificity and function is extremely low ( Shugay et al, 2018 ; Zvyagin et al, 2020 ).…”
Section: Discussionmentioning
confidence: 57%